Alfa Vitamins Laboratories, Inc. Recall: FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.
United States
TerminatedClass III
- Company
- Alfa Vitamins Laboratories, Inc.
- Product
- CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for:…
- Recall date
- March 24, 2020
- Terminated
- August 25, 2020
- Source
- FDA
Reason for recall
FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.
- - Recall initiated
- - Reported by source
- - Recall terminated
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL | Not published in this source record | 1877 bottles | LOT 31453 MFG 06 2019 EXP 06 2022 |
Distribution
- Domestic distribution only.
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- F-0926-2020
- Event ID
- 85317
- Status
- Terminated
- Classification
- Class III
- Company
- Alfa Vitamins Laboratories, Inc.
- Product description
- CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL
- Quantity
- 1877 bottles
- Reason
- FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.
- Recall initiation date
- March 24, 2020
- Report date
- May 6, 2020
- Classification date
- Not published in this source record
- Termination date
- August 25, 2020
- Distribution pattern
- Domestic distribution only.
- UPC, lot, and code information
- LOT 31453 MFG 06 2019 EXP 06 2022
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Responsible company: Alfa Vitamins Laboratories, Inc.
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class III mean?
A situation in which use of or exposure to a product is not likely to cause adverse health consequences.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
Where can I find more official information?
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
